Pipeline

MPS II, Hunter syndrome

Maroteaux-Lamy syndrome, Mucopolysaccharidosis type VI (INN: galsulfase)

Plaque psoriasis (interleukin inhibitor)

Systemic juvenile idiopathic arthritis (INN: canakinumab)

Rheumatoid arthritis (INN: tocilizumab)

Multiple sclerosis (INN: natalizumab)

Acute lymphoblastic leukemia (bispecific antibody, T-cells engager)

Myocardial Infarction